Safety Information - September 8, 2008

Judge Rules: 'Tattoo Ink Must Have Warning Label'

September 22, 2005 - Topics women, child, pregnant and safety
A California Superior Court judge, citing health risks of lead and arsenic in tattoo inks, has ordered two major tattoo-ink manufacturers to carry warning labels, according to a CNN medical report.

The preliminary injunction granted by Judge Irving Feffer also requires Huck Spaulding Enterprises of New York and Superior Tattoo Equipment of Phoenix to carry the labels in their catalogs and on their Internet sites aimed at California customers

read more >>

Tattoo Ink Must Have Warning Label

September 22, 2005 - Topics women, child, pregnant and safety
A California Superior Court judge, citing health risks of lead and arsenic in tattoo inks, has ordered two major tattoo-ink manufacturers to carry warning labels, according to a CNN medical report.

The preliminary injunction granted by Judge Irving Feffer also requires Huck Spaulding Enterprises of New York and Superior Tattoo Equipment of Phoenix to carry the labels in their catalogs and on their Internet sites aimed at California customers

read more >>

FDA Approves Second Silicone Implant Manufacturer

September 22, 2005 - Topics fda, safety, food and infection
The Food and Drug Administration tentatively approves the manufacturing of silicone breast implants by Inamed Corp.

The move brings the company closer to returning the implants to the market years after they were banned

read more >>

MRI Restrictions May Prove Harmful For Patients

September 20, 2005 - Topics cancer, child, europe, research and safety
Experts worry European laws restricting emission limits for medical staff will hurt research and harm patients.

By 2008, it will be illegal for workers to be exposed to electromagnetic fields higher than 300GHz

read more >>

New Drug Offers Hope For Rheumatoid Arthritis Sufferers

September 15, 2005 - Topics arthritis, medicine, safety, food and study
According to a study published this week, rheumatoid arthritis sufferers who do not get adequate relief from TNF-inhibitors, like etanercept or infliximab, a new drug may provide significant clinical and functional benefits.

Made by Bristol-Myers Squibb, Orencia is the first in a new class of drugs for the condition. On Sept. 6, an advisory panel to the Food and Drug Administration unanimously agreed the benefits of Orencia outweigh the risks and recommended the drug receive marketing approval

read more >>





© Copyright 2008 Webmedia Publishing, SA - all rights reserved.     Contact Us  |  Privacy Policy  |  Disclaimer  |  Terms of Use